Standing Order
All companies

Biotech

Tempus AI, Inc.

TEMNASDAQpure-play
Market cap$9.1B
Conviction4/ 5
HQChicago, Illinois, USA

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Price · 180d

$50.47

-31.9%

Thesis

Tempus AI builds a multimodal clinical and molecular data platform spanning diagnostics, genomic sequencing, and data licensing. Its scaled real-world datasets support both precision diagnostics and AI-enabled drug discovery partnerships.

Catalysts

  • Genomics and diagnostics testing volume growth
  • Data-licensing and pharma partnership expansion
  • Margin progression as the platform scales

Not financial advice — research and opinion only. Disclosures